Page URL: https://www.bionews.org.uk/0213
CONTENTS Issue #213
COMMENT
Ethics and safety in the 'saviour child' debate
NEWS DIGEST
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 


Visit the BioNews website at www.bionews.org.uk where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Ethics and safety in the 'saviour child' debate
23 June 2003 - by Juliet Tizzard
This week, the British media has gone crazy about a newborn baby. His name is James Whitaker and he was conceived in order to provide stem cells for his older brother, Charlie. In the reams of commentary which followed James' arrival into the world, two main ethical issues emerged. The... [Read More]
Whitakers have their tissue matched baby
19 June 2003 - by BioNews
A British couple have succeeded in their quest to have a tissue matched baby. Last summer, the Whitakers asked the UK's Human Fertilisation and Embryology Authority (HFEA) to allow them to use embryo screening (PGD) to provide a bone marrow donor for their sick son. After their request was refused... [Read More]
First aneuploidy screening success
18 June 2003 - by BioNews
An embryo screening technique that was licensed by the UK's Human Fertilisation and Embryology Authority (HFEA) last September has resulted in its first pregnancy in the UK. Two UK clinics were initially given licences to perform aneuploidy screening: CARE in the Park, Nottingham and the Assisted Reproduction and Gynaecology Centre... [Read More]
Y chromosome reveals surprising secrets
20 June 2003 - by BioNews
Scientists have unveiled a detailed analysis of the human Y chromosome, the genetic material that contains the 'male' switch. When flipped on, this switch (a gene called SRY) makes an early embryo develop into a baby boy. For many years, this was thought to be the Y chromosome's one important... [Read More]
Gene clues to risky lifestyles
20 June 2003 - by BioNews
Some people may inherit versions of genes that make them more likely to adopt a lifestyle that increases their risk of developing cancer, a new study suggests. The findings, published in the journal Molecular Psychiatry, show that some gene variants may make a person more anxious or depressed, and so... [Read More]
American Medical Association supports cloning research
23 June 2003 - by BioNews
At its annual meeting in Chicago, US, last week, the American Medical Association (AMA) voted in support of the use of cloning technology in medical research. This is the first time the 260,000-member organisation has voiced its opinion on the matter. But, in a report written by its ethics... [Read More]
Dolly firm struggles to survive
23 June 2003 - by BioNews
PPL Therapeutics, the biotechnology firm formed by the creators of Dolly the cloned sheep, faces liquidation this week, unless its shareholders back a last-minute survival plan. Chief executive Geoff Cook is holding a series of emergency meetings with investors, following news that the firm is to halt development of a... [Read More]
Whitaker case sparks calls for legal change
23 June 2003 - by BioNews
James Whitaker's birth has provoked calls for fertility laws in the UK to be reformed. The Human Fertilisation and Embryology Act 1990 is now out of date due to advances in embryology and fertility treatments, say its critics, and it should be changed to allow the tissue typing procedure to... [Read More]
Fertility doctor's libel trial success
23 June 2003 - by BioNews
Dr Geeta Nargund, former director of the Diana, Princess of Wales Centre for Reproductive Medicine at St George's Hospital in London, has won the libel proceedings she issued in London's High Court against St George's Healthcare NHS Trust. It is reported that she has accepted an 'undisclosed' sum in damages... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at snorcross@progress.org.uk

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX